Faculté de Médecine Henri Warembourg
Fibrosis in immune-mediated inflammatory diseases: from pathophysiology to innovative treatment
Event Date : 29/06/2021
The Institut for Translational Research in Inflammation (INFINITE U1286 ULille | Inserm | CHU Lille), in collaboration with the translational gastroenterology laboratory of the Interdisciplinary Center for Biomedical Research (GIGA) from the University of Liège | CHU Liège directed by Prof. Edouard LOUIS, organizes an International Symposium
The scientific event will bring together national and international experts on fibrosis complicating chronic inflammatory diseases (MIC) over one day. Fibrosis is a major health problem in modern societies. It is a complication of a broad spectrum of chronic diseases including IBD and it has a significant impact on morbidity and mortality, mainly due to organ dysfunction. Almost 45% of deaths in the developed world are attributable to fibrosis. However, the cellular and molecular mechanisms leading to fibrosis in MICs are far from fully understood. The consequence is the virtual absence of approved treatment, contrasting with the major impact of this complication
INFINITE has among its research themes the understanding of the mechanisms of fibrosis complicating chronic inflammatory diseases in order to lead to innovative treatments
The translational gastroenterology laboratory of the GIGA research center (ULiège) focuses on understanding the pathophysiological aspects of inflammatory bowel diseases and their consequences, such as intestinal fibrosis.
Provisional program
Clinical Session | Speakers | Topics | ||
Moderators: Pr David Launay et Pr Renaud Louis | ||||
9h15 | INTRODUCTION |
|
| |
9h30-9h45 | Oral clinical communication 1 | Liège | Julien GUIOT | Fibrosing lung diseases |
9h45-10h00 | Oral clinical communication 2 | Liège | Julien GUIOT | Lung fibrosis in rheumatic diseases |
10h00-10h15 | Oral clinical communication 3 | Lille | Vincent SOBANSKI | Endotypes in systemic fibrosing diseases |
10h15-10h30 | Oral clinical communication 4 | Lille | Guillaume Lassailly |
|
10h30-10h45 | Break |
|
|
|
10h45-11h15 | Plenary Local speaker | Liège | Edouard LOUIS | Management of stenonis in Crohn Disease |
11h15-11h45 | Plenary International speaker | Zurich | Oliver DISTLER | Innovative treatment in fibrosis: application in inflammatory disease stages |
11h45-13h15 | Break |
|
|
|
Fundamental Session | Speakers | Topics | ||
Moderators: Laurent Dubuquoy et Marie-Alice Newis | ||||
13h15-14h15 | Plenary International speaker |
| Florian RIEDER | Mechanisms of intestinal fibrosis in IBD |
14h15-14h45 | Plenary Local speaker | Lille | Silvia SPECA | The life cycle and heterogeneity of fibroblasts: an overview of their role in IMIDs-associated fibrotic diseases outcome |
14h45-15h00 | Break |
|
|
|
15h00-15h15 | Fundamental Oral Communication 1 | Lille | Aurélien CHEPY | Profibrotic role of autoantibodies: systemic sclerosis paradigm |
15h15-15h30 | Fundamental Oral Communication 2 | Lille | Line Ntandja Wandji |
|
15h30-15h45 | Fundamental Oral Communication 3 | Liège | Sophie VIEUJEAN | AG2R role inintestinal fibrosis in Crohn disease |
15h45-16h00 | Fundamental Oral Communication 4 | Liège | Celine DEROYER | Fibrosis in arthrosis: role of Cemip |
16h | Conclusion |
|
|
|
Fibrosis in immune-mediated inflammatory diseases : from pathophysiology to innovative treatment-International Symposium (lille-inflammation-research.org)
